A Study of Antitumor (Phase II) and Immunosuppressive Effects of ICRF-159 in Patients with Metastatic Melanoma.

Autor: BELLET, R. E., CATALANO, R. B., DANNA, V. G., BERD, D. A., BERKELHAMMER, J., MASTRANGELO, M. J.
Zdroj: Journal of Clinical Pharmacology; Aug1976, Vol. 16 Issue 8/9, p433-438, 6p
Databáze: Complementary Index
Externí odkaz: